⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3318330 | 1.00 | — | — | |
| SCHEMBL3414553 | 1.00 | — | — | |
| SCHEMBL7730742 | 0.85 | LMNA (0.60) | — | |
| SCHEMBL15829075 | 0.80 | LMNA (0.47) | — | |
| SCHEMBL7647685 | 0.78 | LMNA (0.45) | — | |
| SCHEMBL31633561 | 0.76 | LMNA (0.50) | — | |
| SCHEMBL28639339 | 0.76 | LMNA (0.50) | — | |
| Ether SCHEMBL9720166 | 0.76 | LMNA (0.50) | — | |
| SCHEMBL19565562 | 0.76 | LMNA (0.43) | — | |
| SCHEMBL18469734 | 0.76 | LMNA (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257414-A1 | NUCLEOTIDE ANALOGUES | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-08-17 | — | — | US | disclosed |
| US-20230203083-A1 | NUCLEOTIDE ANALOGUES | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-06-29 | — | — | US | disclosed |
| US-20130060013-A1 | Compounds useful for treating neurodegenerative disorders | SATORI PHARMACEUTICALS, INC. (US) | 2013-03-07 | — | — | US | disclosed |
| US-7705146-B2 | Hepatitis C inhibitor peptide analogs | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-04-27 | — | — | US | disclosed |
| US-20070110772-A1 | VACCINES FOR BLOCKING TRANSMISSION OF PLASMODIUM VIVAX | THE GOVT. OF THE U.S.A. AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2007-05-17 | — | — | US | disclosed |